Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene
April 12, 2019 at 18:32 PM EDT
Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|